On March 14, 2018 CBT Pharmaceuticals (CBT), a U.S. and China-based innovative biopharmaceutical company committed to becoming a leader in the discovery and development of oncology combination therapies, reported that the company reported that it will present at two upcoming investor conferences (Press release, CBT Pharmaceuticals, MAR 14, 2018, View Source [SID1234524758]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

March 23, 2018 – Future Leaders in the Biotech Industry at 2:45 – 3:00 p.m. EST in New York, N.Y.
March 28, 2018 – China Healthcare Investment Conference (CHIC) at 3:15 – 5:15 p.m. CST in Shanghai, P.R. China